Stockholders' Equity (Tables)

9 Months Ended

Mar. 31, 2023

Summary of Stock Based Compensation Cost from Stock Options, RSUs and ESPP

Stock-based compensation cost by award type (in thousands):


	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Stock options	$	8,328	$	14,289	$	33,239	$	42,191
RSUs(1)	49,473		36,255		206,409		93,487
Performance-based awards	4,969		—		11,416		—
Market-based RSUs	990		1,164		3,497		1,394
Employee stock purchase plan	2,561		2,195		8,344		6,359
Total stock-based compensation cost	$	66,321	$	53,903	$	262,905	$	143,431

Stock-based compensation cost was included in the following line items in the accompanying condensed consolidated statements of operations and condensed consolidated balance sheets (in thousands):


	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Cost of revenue	$	2,421	$	1,262	$	6,720	$	3,674
Research and development	22,319		13,912		70,151		38,752
Sales and marketing(1)	18,162		17,758		116,941		36,911
General and administrative	20,888		19,878		62,040		61,044
Total amount charged to expense	63,790		52,810		255,852		140,381
Property and equipment (capitalized internal-use software)	2,531		1,093		7,053		3,050
Total stock-based compensation cost	$	66,321	$	53,903	$	262,905	$	143,431

(1) In October 2022, the Company entered into separation and advisory agreements with its former Chief Revenue Officer (the CRO Agreements). Pursuant to the CRO Agreements, the former CRO will serve the Company as an advisor through September 2024. Upon execution of the CRO Agreements, the Company recognized $52.2 million of stock-based compensation expense related to the former CRO's RSUs.